Innovations seek Medicare add-on payments, as US industry asks for clearer coverage definitions:
This article was originally published in Clinica
Executive Summary
Two US device companies - Cardica and St Francis Technologies - are seeking Medicare's new technology add-on payments in fiscal year 2007 to help defray the added cost of these novel products. Cardica is requesting the payment for its C-Port Distal Anastomosis System for patients who need a vein as a conduit during a coronary bypass operation. It would replace a conventional hand-sewn anastomosis, which typically uses 8-14 sutures evenly-placed around the periphery of a thin-walled vein graft to connect it to the patient's small coronary artery. The C-Port is capable of placing the same number of automatic sutures in a mere 20 seconds, "a huge advance" - compared to 10 minutes for a conventional hand-sutured anastomosis, Indianapolis cardiac surgeon Keith Allen explained during the Centers for Medicare & Medicaid Services (CMS) new technology Town Hall meeting in Baltimore, on February 16.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.